Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Carotid and Renal Artery Stents market for the year 2020 and beyond. Three types of therapies are recommended for carotid stenosis. These therapies include medication, endovascular intervention, and endarterectomy.
Endarterectomy is recommended over stenting to patients who are suffering from stenosis (>70%) and have had symptoms for the last six months to a year. It is not recommended to individuals with 50% or less stenosis in the carotid artery. Endovascular therapy is a new option available to treat carotid stenosis. Endovascular treatment is a minimally invasive procedure using a stent to open the artery in the affected area. Whereas, RAS is primarily caused by two indications, Atherosclerotic Renal Artery Stenosis (ARAS) and Renal Fibromuscular Dysplasia (FMD).
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are –
Currently marketed Carotid and Renal Artery Stents and evolving competitive landscape –
– Insightful review of the key industry trends.
– Annualized total Carotid and Renal Artery Stents market revenue by segment and market outlooks from 2015-2033.
– Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights –
– Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
– SWOT analysis for Carotid and Renal Artery Stents market.
– Competitive dynamics insights and trends provided for Carotid and Renal Artery Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country specific overview of the healthcare system.
– Country specific reimbursement policies.
– Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Cordis Corp, Boston Scientific Corp, Silk Road Medical Inc, Medtronic Plc, Terumo Corp, Cook Medical Inc, Biotronik SE & Co KG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Carotid and Renal Artery Stents Market Dynamics
Stents have better outcomes than open surgery. In the case of carotid artery stenosis (CAS), open surgery has the risk of developing debilitating and life-altering pharyngolaryngeal dysfunction. Bare metal stents are preferred over open surgery in cases where neck lesion open surgery is unfavorable.
Based on CAS prevalence, with its subsequent racial distribution effect within populations, and renal artery stenosis (RAS) prevalence, rapid carotid and renal artery stents market growth is expected, particularly in Europe, Africa, Latin America, and Asia. This growth rate is slightly lower in North America as compared to other regions.
Technological advancements in this field are expected to drive continual growth and innovation due to the reduced complication rates and better patient outcomes that are possible with carotid and renal stenting. Despite issues with recurrent stenosis, the advanced capabilities of the device to dramatically increase the safety and outcomes of patients undergoing treatment are expected to encourage companies to invest in this technology and to draw new players to enter the market.
Carotid and Renal Artery Stents Market Segments
The key segments in the carotid and renal artery stents market are carotid artery bare metal stents, renal artery bare metal stents, and transcarotid stent systems. Carotid artery bare metal stents led the carotid and renal artery stents market in 2023. A carotid artery bare metal stent is a metal-mesh tube that is implanted to increase the flow of blood in a narrowed carotid artery.
Carotid and Renal Artery Stents Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Carotid and Renal Artery Stents Market
Carotid and Renal Artery Stents Market Segmentation by Regions
The key regions in the carotid and renal artery stents market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, Europe dominated the carotid and renal artery stents market. Carotid artery stenting will increase in the region but at a slow pace as it is difficult to properly diagnose carotid artery stenosis. Additionally, doctors prefer open surgery over stenting. However, renal artery stenting will increase at a significant rate as doctors prefer stenting in cases of severe renal deterioration or cases of refractory hypertension.
Carotid and Renal Artery Stents Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Carotid and Renal Artery Stents Market
Carotid and Renal Artery Stents Market - Competitive Landscape
A few of the leading companies in the carotid and renal artery stents market are:
- Abbott Laboratories
- Boston Scientific Corp
- Cordis Corp
- Medtronic Plc
- Silk Road Medical Inc
Abbott Laboratories dominated the market in 2023.
Carotid and Renal Artery Stents Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company Insights into the Carotid and Renal Artery Stents Market
Segments Covered in the Report
Carotid and Renal Artery Stents Segments Outlook (Value, $ Billion, 2015-2033)
- Carotid Artery Bare Metal Stents
- Renal Artery Bare Metal Stents
- Transcarotid Stent System
Carotid and Renal Artery Stents Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East & Africa
Key Inclusions
Currently marketed Carotid and Renal Artery Stents and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Carotid and Renal Artery Stents market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Carotid and Renal Artery Stents market.
- Competitive dynamics insights and trends provided for the Carotid and Renal Artery Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories , Hellman and Friedman LLC , Boston Scientific Corp , Silk Road Medical Inc , Medtronic Plc, Terumo Corp, Cook Group Inc, Biotronik SE & Co KG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
– CMO executives who must have deep understanding of the Carotid and Renal Artery Stents marketplace to make strategic planning and investment decisions.
– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Key Highlights
Reasons to Buy
The model will enable you to –
– Understand the impact of COVID-19 on Carotid and Renal Artery Stents market.
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving Carotid and Renal Artery Stents market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Carotid and Renal Artery Stents market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track device sales in the global and country-specific Carotid and Renal Artery Stents market from 2015-2033.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Cordis Corp
Boston Scientific Corp
Silk Road Medical Inc
Medtronic Plc
Terumo Corp
Cook Medical Inc
Biotronik SE & Co KG
Others
Frequently asked questions
-
What was the carotid and renal artery stents market size in 2023?
The carotid and renal artery stents market size was $1.09 billion in 2023.
-
What will the carotid and renal artery stents market growth rate be during the forecast period?
The carotid and renal artery stents market is expected to grow at a CAGR of more than 3% during 2023-2033.
-
Which region dominated the carotid and renal artery stents market in 2023?
Europe dominated the overall carotid and renal artery stents market in 2023.
-
Which segment led the carotid and renal artery stents market in 2023?
Carotid artery bare metal stents led the carotid and renal artery stents market in 2023.
-
Which are the leading companies in the carotid and renal artery stents market?
A few of the leading companies in the carotid and renal artery stents market are Abbott Laboratories, Boston Scientific Corp, Cordis Corp, Medtronic Plc, and Silk Road Medical Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.